Direct-to-consumer pharmaceutical advertising is under increasing political pressure, with bipartisan legislation being introduced to ban or restrict the practice, and states considering bills to deny tax deductions for pharmaceutical advertising expenses.
Is this the end of costly and harmful pharmaceutical advertising?
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Trump warns likely next DC mayor against ‘communist’ policies
Administration Trump warns likely next DC mayor against ‘communist’ policies Comments: by Max Rego - 06/28/26 5:21 PM ET...
Chris Mason: Burnham starts to sketch out his vision as potential prime minister
Image source, EPAByChris MasonPolitical editorPublished39 minutes agoAndy Burnham will give what his team has called &qu...
MAHA feels betrayed after Supreme Court ruling on Monsanto, glyphosate
Healthcare MAHA feels betrayed after Supreme Court ruling on Monsanto, glyphosate Comments: by Nathaniel Weixel and Rach...
Three firefighters die in Colorado blaze
State Watch Three firefighters die in Colorado blaze Comments: by Tara Suter - 06/28/26 4:37 PM ET Comments: Link copie...